EU practical, legal steps against fake drugs An investigation into pharmaceutical companies conducted by the European Commission has followed up a preliminary report made public last November warning them not to use anti-competitive practices.
Some drugmakers are suspected of arranging with generics producers to hold back cheap medicines in deals that cost healthcare providers billions of euros. Delays in bringing less expensive generic drugs to the market pushed up consumers’ bills by 20 percent between 2000 and 2007, Brussels says. A drug industry body welcomed the latest report, saying it shed light on regulatory barriers hindering the industry.More about: Health, Pharmaceutical companiesCopyright © 2012 euronews
Top Stories
Greek debt deal sparks protests and a strike
Their political leaders may be breathing a sigh of relief. However, Greeks protesting outside parliament are far from happy that…
Deadly shelling continues in Homs
In Syria, the heavy bombardment of opposition-held neighbourhoods in Homs is reportedly…
Spain's 'human rights' judge Garzón convicted
Spain’s best-known judge, who achieved international fame for his human rights…
latest europe news
Euro-zone weighs Greek deal- EU-India: trade deal fading fast?
- Maastricht with hindsight
- Greece dices with default
- Brussels homeless battle big freeze
- NATO talks focus on early Afghan handover
- Europe’s silver workforce Tsunami
- Greece’s euro exit: is it only a matter of time?
- EU enlargement: In search of the next Croatia
- EU reaction to French ‘genocide’ bill
euronews on facebook
